---
title: "Ocrelizumab - Primary Progressive Multiple Sclerosis - 2"
sidebar: mydoc_sidebar
permalink: db11988-mesh-d020528-2.html
toc: false 
---


Path ID: `DB11988_MESH_D020528_2`
{% include image.html url="images/db11988-mesh-d020528-2.png" file="db11988-mesh-d020528-2.png" alt="db11988-mesh-d020528-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C533411 | Ocrelizumab | Drug |
| GO:0001788 | Antibody-dependent cellular cytotoxicity | BiologicalProcess |
| GO:0001783 | B cell apoptotic process | BiologicalProcess |
| MESH:D020528 | Primary progressive multiple sclerosis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Ocrelizumab | POSITIVELY REGULATES | Antibody-Dependent Cellular Cytotoxicity |
| Antibody-Dependent Cellular Cytotoxicity | PRECEDES | B Cell Apoptotic Process |
| B Cell Apoptotic Process | NEGATIVELY CORRELATED WITH | Primary Progressive Multiple Sclerosis |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB11988](https://go.drugbank.com/drugs/DB11988)
